Sun Pharma shares fall 7.5% after whistleblower email to Sebi
The whistleblower email claims Sun Pharma promoter Dilip Shanghvi and his brother-in-law Sudhir Valia engaged in financial irregularities with stock market scam accused Dharmesh Doshi
Mumbai: Sun Pharmaceutical Industries Ltd founder and managing director Dilip Shanghvi and his brother-in-law Sudhir Valia engaged in financial irregularities with Dharmesh Doshi, a key figure from the 2001 Ketan Parekh scam, a whistleblower alleged. The whistleblower made the allegations in a 150-page letter sent to the Securities and Exchange Board of India (Sebi), which had banned Doshi and Parekh following the 2001 scam, India’s second biggest stock exchange scandal. Doshi is a former associate of Parekh.